The Prostate Cancer Prevention Trial (PCPT) showed that treatment with finasteride (a 5α-reductase inhibitor) could lower the number of prostate cancers diagnosed in the U.S. each year by about 25 percent. … READ MORE …
Filed under: Diagnosis, Prevention, Risk | Tagged: death, finasteride, mortality, PCPT, Prevention, survival | 5 Comments »
Search for new and
ongoing trials on the
CTAG PCa web site